510 related articles for article (PubMed ID: 27476742)
1. Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.
Teira R; Vidal F; Muñoz-Sánchez P; Geijo P; Viciana P; Ribera E; Domingo P; Castaño M; Martínez E; Roca B; Puig T; Estrada V; Deig E; Galindo MJ; de la Fuente B; Lozano F; Montero M; Muñoz-Sanz A; Sanchez T; Terrón A; Romero-Palacios A; Lacalle JR; Garrido M; Suárez-Lozano I;
HIV Med; 2017 Mar; 18(3):196-203. PubMed ID: 27476742
[TBL] [Abstract][Full Text] [Related]
2. Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?
Pernas B; Grandal M; Pertega S; Cañizares A; Castro-Iglesias Á; Mena Á; Rodriguez-Osorio I; Tabernilla A; Pedreira JD; Poveda E
J Antimicrob Chemother; 2016 Apr; 71(4):1051-5. PubMed ID: 26702924
[TBL] [Abstract][Full Text] [Related]
3. Is HIV-1 viraemia below 20 copies/mL in antiretroviral-treated patients associated with virologic outcome?
den Oudsten M; van Kampen J; Rijnders B; van de Vijver D; van der Ende M
Infect Dis (Lond); 2019 Apr; 51(4):259-267. PubMed ID: 30729841
[TBL] [Abstract][Full Text] [Related]
4. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
Hermans LE; Moorhouse M; Carmona S; Grobbee DE; Hofstra LM; Richman DD; Tempelman HA; Venter WDF; Wensing AMJ
Lancet Infect Dis; 2018 Feb; 18(2):188-197. PubMed ID: 29158101
[TBL] [Abstract][Full Text] [Related]
5. Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study).
Vandenhende MA; Perrier A; Bonnet F; Lazaro E; Cazanave C; Reigadas S; Chêne G; Morlat P;
Antivir Ther; 2015; 20(6):655-60. PubMed ID: 25735799
[TBL] [Abstract][Full Text] [Related]
6. Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study.
Helou E; Shenoi S; Kyriakides T; Landry ML; Kozal M; Barakat LA
J Int Assoc Provid AIDS Care; 2017; 16(3):261-266. PubMed ID: 27903948
[TBL] [Abstract][Full Text] [Related]
7. Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy.
Sungkanuparph S; Groger RK; Overton ET; Fraser VJ; Powderly WG
HIV Med; 2006 Oct; 7(7):437-41. PubMed ID: 16925729
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients.
Calcagno A; Motta I; Ghisetti V; Lo Re S; Allice T; Marinaro L; Milia MG; Tettoni MC; Trentini L; Orofino G; Salassa B; Di Perri G; Bonora S
AIDS Res Hum Retroviruses; 2015 Oct; 31(10):999-1008. PubMed ID: 26165150
[TBL] [Abstract][Full Text] [Related]
9. The significance of very low-level viraemia detected by sensitive viral load assays in HIV infected patients on HAART.
Widdrington J; Payne B; Medhi M; Valappil M; Schmid ML
J Infect; 2011 Jan; 62(1):87-92. PubMed ID: 21073896
[TBL] [Abstract][Full Text] [Related]
10. Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.
Meybeck A; Alidjinou EK; Huleux T; Boucher A; Tetart M; Choisy P; Bocket L; Ajana F; Robineau O
AIDS Patient Care STDS; 2020 Feb; 34(2):51-58. PubMed ID: 32049556
[TBL] [Abstract][Full Text] [Related]
11. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients.
; Vandenhende MA; Ingle S; May M; Chene G; Zangerle R; Van Sighem A; Gill MJ; Schwarze-Zander C; Hernandez-Novoa B; Obel N; Kirk O; Abgrall S; Guest J; Samji H; D'Arminio Monforte A; Llibre JM; Smith C; Cavassini M; Burkholder GA; Shepherd B; Crane HM; Sterne J; Morlat P
AIDS; 2015 Jan; 29(3):373-83. PubMed ID: 25686685
[TBL] [Abstract][Full Text] [Related]
12. Impact of low-level viraemia on virological failure in HIV-1-infected patients with stable antiretroviral treatment.
Navarro J; Caballero E; Curran A; Burgos J; Ocaña I; Falcó V; Torrella A; Pérez M; Ribera E; Crespo M
Antivir Ther; 2016; 21(4):345-52. PubMed ID: 26756461
[TBL] [Abstract][Full Text] [Related]
13. HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.
Kiweewa F; Esber A; Musingye E; Reed D; Crowell TA; Cham F; Semwogerere M; Namagembe R; Nambuya A; Kafeero C; Tindikahwa A; Eller LA; Millard M; Gelderblom HC; Keshinro B; Adamu Y; Maswai J; Owuoth J; Sing'oei VC; Maganga L; Bahemana E; Khamadi S; Robb ML; Ake JA; Polyak CS; Kibuuka H
PLoS One; 2019; 14(2):e0211344. PubMed ID: 30721233
[TBL] [Abstract][Full Text] [Related]
14. Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure.
Joya C; Won SH; Schofield C; Lalani T; Maves RC; Kronmann K; Deiss R; Okulicz J; Agan BK; Ganesan A
Clin Infect Dis; 2019 Nov; 69(12):2145-2152. PubMed ID: 30785191
[TBL] [Abstract][Full Text] [Related]
15. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
[TBL] [Abstract][Full Text] [Related]
16. Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort.
Elvstam O; Malmborn K; Elén S; Marrone G; García F; Zazzi M; Sönnerborg A; Böhm M; Seguin-Devaux C; Björkman P
Clin Infect Dis; 2023 Jan; 76(1):25-31. PubMed ID: 36100984
[TBL] [Abstract][Full Text] [Related]
17. Early HIV viral load determination after initiating first-line antiretroviral therapy for indentifying patients with high risk of developing virological failure: data from a cohort study in a resource-limited setting.
Alvarez-Uria G; Naik PK; Pakam R; Midde M
Trop Med Int Health; 2012 Sep; 17(9):1152-5. PubMed ID: 22487689
[TBL] [Abstract][Full Text] [Related]
18. Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study.
Sudjaritruk T; Teeraananchai S; Kariminia A; Lapphra K; Kumarasamy N; Fong MS; Hansudewechakul R; Bunupuradah T; Ly PS; Nallusamy RA; Sohn AH; Sirisanthana V;
J Int AIDS Soc; 2020 Jul; 23(7):e25550. PubMed ID: 32628816
[TBL] [Abstract][Full Text] [Related]
19. Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study.
Boillat-Blanco N; Darling KE; Schoni-Affolter F; Vuichard D; Rougemont M; Fulchini R; Bernasconi E; Aouri M; Clerc O; Furrer H; Günthard HF; Cavassini M;
Antivir Ther; 2015; 20(2):165-75. PubMed ID: 24964403
[TBL] [Abstract][Full Text] [Related]
20. First-line antiretroviral therapy durability in a 10-year cohort of naïve adults started on treatment in Uganda.
Castelnuovo B; Kiragga A; Mubiru F; Kambugu A; Kamya M; Reynolds SJ
J Int AIDS Soc; 2016; 19(1):20773. PubMed ID: 27319742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
